fluorodeoxyglucose f18 has been researched along with Myocardial Ischemia in 173 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 52 (30.06) | 18.2507 |
| 2000's | 75 (43.35) | 29.6817 |
| 2010's | 32 (18.50) | 24.3611 |
| 2020's | 14 (8.09) | 2.80 |
| Authors | Studies |
|---|---|
| Alhouri, A; Alresheq, MZ; Doudeen, RM; Halasa, M; Juweid, ME; Sayej, M | 1 |
| Acampa, W; Assante, R; Buongiorno, P; Cuocolo, A; D'Antonio, A; Gaudieri, V; Mainolfi, CG; Mannarino, T; Nappi, C; Panico, M; Petretta, M; Spinelli, L; Zampella, E | 1 |
| Bandyopadhyay, D; Goel, A; He, ZX; Jain, D; Yang, MF | 1 |
| Aikawa, T; Fujita, H; Manabe, O; Oshiro, H; Oyama-Manabe, N; Sakakura, K; Takahashi, K; Tsukui, T; Yoshimura, K | 1 |
| Al-Mallah, MH; Chamsi-Pasha, M; Khalaf, S | 1 |
| Benz, DC; Buechel, RR; Fuchs, TA; Gaemperli, O; Giannopoulos, AA; Gräni, C; Grossmann, M; Kaufmann, PA; Markendorf, S; Messerli, M; Patriki, D; Pazhenkottil, AP | 1 |
| Li, W; Li, X; Mi, H; Tian, Y; Zhang, X; Zhao, M; Zhu, Z | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Andersen, FL; Hasbak, P; Hornnes, C; Højgaard, L; Ladefoged, CN | 1 |
| Buechel, R; Caobelli, F; Kamani, CH; Nkoulou, R | 1 |
| Civelek, AC; He, ZX; Li, XF; Li, YM; Yao, Y | 1 |
| Gormsen, LC; Kjærulff, MLBG; Lauritsen, KM; Luong, TV; Madsen, S; Pedersen, MGB; Søndergaard, E; Tolbod, LP | 1 |
| Abouzied, M; Almuhaideb, A; Alsugair, A; Fathala, A | 1 |
| Dou, KF; Fang, W; Feng, L; He, ZX; Lu, MJ; Wang, J; Wang, L; Yang, MF; Zhao, SH | 1 |
| Chiu, KM; Hsu, JC; Ko, KY; Lee, CL; Shiau, YC; Tsai, HY; Wang, SY; Wu, YW; Yen, RF | 1 |
| Bhambhvani, P; Farag, A; Hage, FG; Valentin, RC | 1 |
| Bengel, FM; Thackeray, JT | 1 |
| Bhambhvani, P; Hage, FG; Iskandrian, AE | 1 |
| Benz, DC; Buechel, RR; Ferro, P; Fuchs, TA; Gebhard, C; Giannopoulos, AA; Gräni, C; Huang, W; Kaufmann, PA; Messerli, M; Patriki, D; Pazhenkottil, AP; Safa, N; von Felten, E | 1 |
| Benetos, G; Benz, DC; Buechel, RR; Fuchs, TA; Gaemperli, O; Gebhard, C; Giannopoulos, AA; Gräni, C; Huang, W; Kaufmann, PA; Messerli, M; Pazhenkottil, AP; von Dahlen, AP; von Felten, E | 1 |
| Bartenstein, P; Böning, G; Brunner, S; Cumming, P; Franz, WM; Hacker, M; Klingel, K; Lehner, S; Nekolla, SG; Sauter, M; Schirrmacher, R; Todica, A; Übleis, C; Wängler, C; Wildgruber, M | 1 |
| Beanlands, RS; Mc Ardle, BA | 1 |
| Brunken, RC; Cerqueira, MD; Flores, DR; Hachamovitch, R; Jaber, WA; Ling, LF; Marwick, TH | 1 |
| Bartenstein, P; Becker, A; Cumming, P; Hacker, M; Haug, A; Hellweger, S; Laubender, RP; Lehner, S; Slomka, PJ; Sohn, HY; Uebleis, C; Van Kriekinge, SD | 1 |
| Otsuka, H | 1 |
| Brunetti, A; Cuocolo, A; Esposito, G; Gargiulo, S; Gramanzini, M; Greco, A; Larobina, M; Panico, M; Petretta, M; Petretta, MP; Schiattarella, GG | 1 |
| Arun, S; Bhattacharya, A; Mittal, BR; Rohit, MK | 1 |
| He, ZX; Jain, D; Lele, V | 1 |
| He, ZX; Jain, D | 1 |
| Bassiouny, M; Harb, S; Ismaeel, H; Jaber, WA | 1 |
| Ferguson, MT; Hicks, RJ; Hofman, MS; Mallia, A; Wright, S; Yap, K | 1 |
| Jung, JH; Kim, SE; Lee, BC; Lee, MS; Park, HS; Yoo, JS | 1 |
| Carrió, I; Chen, Y; Du, R; Feng, J; Gu, W; Liang, P; Liu, H; Shen, Y; Song, F; Tang, L; Tian, M; Wu, S; Xu, C; Zhang, H; Zhang, K; Zhang, S; Zhu, Y | 1 |
| Bo, P; Ma, YX; Mu, JS; Zhang, JQ | 1 |
| Candell-Riera, J; Esteves, FP; Faber, TL; Folks, RD; Garcia, EV; Ornelas, M; Santana, CA; Santana, LF; Sanyal, R; Soler-Peter, M; Verdes, L | 1 |
| Dou, KF; He, ZX; Jain, D; Yang, MF; Yang, YJ | 1 |
| Dilsizian, V | 2 |
| Aktas, MK; Allen, D; Chuang, HH; Jaber, WA; Taylor, DO; Yamani, MH | 1 |
| Dabeshlim, A; de Sutter, J; Dierckx, RA; Hillege, HL; Siebelink, HM; Slart, RH; Tio, RA; van Veldhuisen, DJ; Zeebregts, CJ; Zijlstra, F | 1 |
| Southworth, R | 1 |
| He, Z; Jiang, S; Li, S; Liu, Q; Liu, Y; Lu, M; Yan, C; Yang, M; Zhang, Y; Zhao, S | 1 |
| Kawasaki, T; Sugihara, H; Yamano, M | 1 |
| Bourdon, A; Ilonca, D; Mariano-Goulart, D | 1 |
| Beanlands, RS; Birnie, D; DeKemp, RA; Guo, A; Lalonde, M; Ruddy, TD; Tang, AS; Wassenar, R; Williams, K | 1 |
| Canty, JM; deKemp, RA; Fallavollita, JA; Luisi, AJ; Yun, E | 1 |
| Ghanbarinia, A; He, ZX; Jain, D | 1 |
| Busch, M; Gawaz, M; Kettering, K; Laszlo, R; Reimold, M; Schreieck, J; Schwegler, AC; Weig, HJ | 1 |
| Buechel, RR; Ghadri, JR; Herzog, BA; Husmann, L; Kaufmann, PA; Nkoulou, R; Pazhenkottil, AP; Valenta, I; Wolfrum, M | 1 |
| Beanlands, RS; Camici, PG; Ghosh, N; Rimoldi, OE | 1 |
| Bergmann, SR; Giedd, KN | 1 |
| Capobianco, J; Gonen, M; Lyall, A; Schöder, H; Strauss, HW | 1 |
| Hashiba, Y; Kariya-Kaneko, Y; Matsuda, M; Okayama, A; Umekita, K | 1 |
| Chubuchny, V; Di Cecco, P; Emdin, M; Ferrannini, E; Guiducci, L; Iozzo, P; Knuuti, J; Lautamäki, R; Masi, S; Morales, MA; Neglia, D; Nuutila, P; Pardini, S; Porciello, C; Salvadori, PA; Sironi, AM | 1 |
| Dahlbom, M; Huang, SC; Prior, JO; Sayre, J; Schelbert, HR; Schindler, TH; Zhang, X | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; Valkema, R | 1 |
| Arendrup, H; Bangsgaard, R; Carstensen, S; Freiberg, J; Hesse, B; Holm, S; Hove, JD; Kelbaek, H; Kofoed, KF; Rabøl, A | 1 |
| Bax, JJ; Knuuti, J; Schelbert, HR | 1 |
| Itoh, Y; Katoh, C; Kubo, N; Kuge, Y; Mabuchi, M; Morita, K; Noriyasu, K; Tamaki, N | 1 |
| Dearling, JL; Flynn, AA; Garlick, PB; Medina, RA; Pedley, RB; Southworth, R | 1 |
| Iozzo, P; L'Abbate, A; Neglia, D; Sambuceti, G; Strauss, HW | 1 |
| Bax, J; Bertella, M; Bigi, R; Celegon, L; Cortigiani, L; Desideri, A; Suzzi, G; Zanco, P | 1 |
| Her, D; Kelly, R; Liow, JS; Marx, D; McFalls, EO; Murad, B; Sikora, J; Ward, HB | 1 |
| Bax, JJ; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; Valkema, R; van Domburg, R; Vourvouri, EC | 1 |
| Garlick, PB; Southworth, R | 1 |
| Beek, AM; Heussen, N; Hofman, MB; Kühl, HP; Lammertsma, AA; van der Weerdt, AP; van Rossum, AC; Visser, CA; Visser, FC | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Geleijnse, ML; Poldermans, D; Roelandt, JR; Schinkel, AF | 1 |
| Bax, JJ; van der Wall, EE | 1 |
| Gao, RL; He, ZX; Jain, D; Liu, XJ; Narula, J; Qin, XW; Shen, R; Shi, RF; Tian, YQ; Wang, SW; Wu, YJ | 1 |
| Camici, PG; Rimoldi, OE | 1 |
| Bax, JJ; Biagini, E; Bountioukos, M; Elhendy, A; Kertai, MD; Krenning, B; Krenning, EP; Poldermans, D; Rizzello, V; Roelandt, JR; Schinkel, AF; Valkema, R; Vourvouri, EC | 1 |
| Apperson-Hansen, C; Brunken, RC; Mills, RM; Nishime, EO; Saber, W | 1 |
| Ando, A; Hirai, M; Ishigaki, T; Isobe, S; Ito, K; Izawa, H; Murohara, T; Nanasato, M; Nonokawa, M; Sobue, T; Yokota, M | 1 |
| Ando, A; Ikeda, M; Isobe, S; Izawa, H; Kato, K; Murohara, T; Nanasato, M; Nonokawa, M; Takeichi, Y; Yokota, M | 1 |
| Beanlands, R; Benard, F; Coates, G; deKemp, RA; Fallen, E; Hendry, P; Humen, D; Iwanochko, RM; Nichol, G; Racine, N; Ross, H; Ruddy, TD; Wells, G | 1 |
| Boellaard, R; Knaapen, P; Lammertsma, AA; van der Weerdt, AP; Visser, CA; Visser, FC | 1 |
| Brunken, RC; Griffin, BP; Kalahasti, V; Pu, M; Rodriguez, D; Thomas, JD; Underwood, D; Yang, H | 1 |
| Gould, KL; Taegtmeyer, H | 1 |
| Chen, IY; Chhabra, A; Crystal, R; Fishbein, MC; Gambhir, SS; Min, JJ; Salek, M; Tseng, JR; Wang, Y; Wu, JC | 1 |
| Aslanidi, IP; Bokeriia, LA; Eremeeva, MV; Golukhova, EZ; Kiselev, SL; Kliueva, AF; Lukashkin, MA; Poliakova, ES; Vakhromeeva, MN | 1 |
| Gavrilovic, G; Haberkorn, U; Hansen, A; Hoffend, J; Korosoglou, G; Kuecherer, H; Wolf, D; Zehelein, J | 1 |
| Iskandrian, AE; Mehta, D | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; van der Wall, EE | 1 |
| Döbert, N; Grünwald, F; Hamscho, N; Menzel, K; Zaplatnikov, K | 1 |
| Bax, JJ; Biagini, E; Poldermans, D; Rambaldi, R; Rizzello, V; Roelandt, JR; Valkema, R | 1 |
| Kofoed, KF | 1 |
| Bax, JJ; Christen, AI; Cortigiani, L; Coscarelli, S; Desideri, A; Gregori, D; Komorovsky, R; Zanco, P | 1 |
| Camici, PG | 1 |
| Abdel-Latif, A; Al-Chekakie, MO; Blackstone, EH; Brunken, R; Lauer, MS; McCarthy, PM; Pothier, CE; Tarakji, KG | 1 |
| Bax, JJ; Biagini, E; Elhendy, A; Krenning, EP; Poldermans, D; Rizzello, V; Schinkel, AF; Simoons, ML; Valkema, R; van Domburg, RT | 1 |
| Battenberg, TF; Buecker, A; Heussen, N; Katoh, M; Krombach, GA; Kühl, HP; Lipke, CS; Nowak, B; Schaefer, WM | 1 |
| Alegria, E; Barba, J; Cañizo, C; Garcia-Velloso, MJ; Gavira, JJ; González-Santos, JM; Hernández, M; Herreros, J; López-Holgado, N; Martí-Climent, JM; Martin-Arnau, A; Martin-Herrero, F; Martín-Luengo, C; Perez, A; Prósper, F | 1 |
| Atsma, DE; Bax, JJ; Beeres, SL; Dibbets, P; Fibbe, WE; Schalij, MJ; Stokkel, MP; van der Wall, EE; Zeppenfeld, K | 1 |
| Correa, PL; de Azevedo, JC; Dohmann, HF; Felix, RC; Mesquita, CT; Mesquita, ET | 1 |
| Hanafusa, K | 1 |
| Bax, JJ; Bleeker, GB; Boersma, E; Dibbets-Schneider, P; Schalij, MJ; Steendijk, P; Stokkel, MP; van der Wall, EE; Ypenburg, C | 1 |
| Comans, EF; de Cock, CC; Knaapen, P; Lammertsma, AA; van Campen, CM; van der Weerdt, AP; Visser, CA; Visser, FC | 1 |
| Mortensen, PT; Rehling, M; Wiggers, H | 1 |
| Abbott, BG; Arrighi, JA; Liu, YH | 1 |
| Chen, LB; Jin, ZY; Kong, LY; Miao, Q; Sun, HY; Wang, YN; Zhang, H; Zhang, ZH; Zhou, L | 1 |
| Ghodsizad, A; Karck, M; Lichtenberg, A; Ruhparwar, A | 1 |
| Yoshinaga, K | 1 |
| Campbell, MG; Delbeke, D; Martin, WH; Ohana, I; Patton, JA; Sandler, MP; Videlefsky, S | 1 |
| Delbeke, D; Martin, WH; Meyerowitz, C; Ohana, I; Patton, JA; Sandler, MP; Videlefsky, S | 1 |
| Knapp, WH | 1 |
| Caldwell, JH; Johnson, PM; Krohn, KA; Martin, GV; Rasey, JS; Revenaugh, JR | 1 |
| McKillop, JH | 1 |
| Clarke, K; Veech, RL | 1 |
| Anthonio, RL; Blanksma, PK; de Jong, RM; Lie, KI; Meeder, JG; Pruim, J; Vaalburg, W; Willemsen, AT | 1 |
| Beanlands, R; Coates, G; Fallen, EL; Garnett, ES; Nahmias, C; Scheffel, A | 1 |
| Ban, T; Kawamoto, M; Konishi, J; Magata, Y; Nishimura, K; Nohara, R; Sasayama, S; Tadamura, E; Tamaki, N; Yonekura, Y | 1 |
| Kawamoto, M; Konishi, J; Magata, Y; Nohara, R; Okuda, K; Sasayama, S; Takahashi, N; Tamaki, N; Yamamoto, K; Yonekura, Y | 1 |
| Chen, EQ; Cook, SA; Go, RT; Kaczur, T; MacIntyre, WJ; Neumann, DR; Saha, GB; Underwood, DA | 1 |
| Bashore, TM; Brezinski, DA; Hanson, MW; Harrison, JK; Van Trigt, P; Wilson, JS | 1 |
| Brunken, RC; Hawkins, RA; Mody, FV; Nienaber, CA; Phelps, ME; Schelbert, HR | 1 |
| Schneider-Eicke, J; Schröter, G; Schwaiger, M | 1 |
| Baer, FM; Schicha, H; Schneider, CA; Sechtem, U; Theissen, P; Voth, E; Wagner, R; Wienhard, K | 1 |
| Fujibayashi, Y; Ikekubo, K; Kato, H; Kawamoto, M; Magata, Y; Nohara, R; Sasayama, S; Tadamura, E; Tamaki, N; Yonekura, Y | 1 |
| Bendriem, B; Castaigne, A; Crozatier, B; Hittinger, L; Mazoyer, B; Merlet, P; Randé, JL; Saal, JP; Syrota, A; Valette, H | 1 |
| Donatelli, F; Grossi, A; Mariani, MA; Pelenghi, S; Zuccari, M | 1 |
| Bianco, JA | 1 |
| Baldwin, DR; Fashingbauer, P; Jaimes, D; McFalls, EO; Nemzek, T; Ward, HB | 1 |
| Kamiya, T; Konishi, J; Magata, Y; Matsumori, A; Nohara, R; Sasayama, S; Tadamura, E; Tamaki, N; Yonekura, Y; Yoshibayashi, M | 1 |
| Calhoun, WB; Drane, WE; Mills, RM | 1 |
| Dynes, A; Lewis, P; Maisey, M; Nunan, T | 1 |
| Abraham, SA; Alpert, NM; Fischman, AJ; Gewirtz, H; Mukerjee, AK; Picard, MH; Skopicki, HA; Weissman, NJ | 1 |
| Bol, A; Gerber, BL; Labar, D; Melin, JA; Michel, C; Vanoverschelde, JL; Wijns, W | 1 |
| Hashimoto, K; Ishida, Y; Kusuoka, H; Nishimura, T; Nonogi, H; Uehara, T | 1 |
| Momose, T; Nishikawa, J; Ohtake, T; Sasaki, Y; Watanabe, T; Yokoyama, I | 1 |
| Nahmias, C; Yu, SK | 1 |
| Delbeke, D; Jones, RC; Martin, WH; Sandler, MP | 1 |
| Cleophas, AJ; Cramer, MJ; Kuijper, AF; Meeder, JG; Niemeyer, MG; van der Wall, EE | 1 |
| Brosius, FC; Egert, S; Nguyen, N; Schwaiger, M | 1 |
| Driver, DR; Randolph, T; Schraml, FV; Silverman, ED | 1 |
| Bøtker, HE; Bøttcher, M; Gjedde, A; Nielsen, TT | 1 |
| McNulty, PH; Ng, CK; Soufer, R | 1 |
| Bax, JJ; Cornel, JH; Poldermans, D; van der Wall, EE; van Eck-Smit, BL | 1 |
| Barton, HJ; Bergin, PJ; Berlangieri, SU; Esmore, DS; Kalff, V; Kelly, MJ; van Every, B | 1 |
| Doenst, T; Taegtmeyer, H | 1 |
| Bonser, RS; Camici, PG; Fath-Ordoubadi, F; Keogh, BE; Marinho, NV; Pagano, D | 1 |
| Drane, WE; Kiser, JW; Mastin, ST; Nicole, MW | 1 |
| Akutsu, Y; Harumi, K; Katagiri, T; Michihata, T; Okazaki, O; Watanabe, T; Yamanaka, H | 1 |
| Blanksma, PK; Crijns, HJ; van den Heuvel, AF; van Veldhuisen, DJ | 1 |
| Bax, JJ; Martin, WH; Patton, JA; Sandler, MP; Visser, FC; Wijns, W | 1 |
| Hasegawa, S; Hori, M; Kusuoka, H; Nishimura, T; Uehara, T; Yamaguchi, H | 1 |
| Camici, PG; Doenst, T; Rhodes, CG; Taegtmeyer, H | 1 |
| Lauer, MS; Lytle, BW; Marwick, TH; Secknus, MA; Williams, J; Zuchowski, C | 1 |
| Egert, S; Nguyen, N; Schwaiger, M | 1 |
| Bøtker, HE; Bøttcher, M; Gjedde, A; Nielsen, TT; Wiggers, H | 1 |
| Garlick, PB; Marsden, PK; Medina, RA; Southworth, R | 1 |
| Bax, JJ; Wijns, W | 1 |
| Blanksma, PK; Crijns, HJ; Siebelink, HM; Vaalburg, WM; van den Heuvel, AF; van der Wall, EE; van Gilst, WH; van Veldhuisen, DJ | 1 |
| Nishimura, T | 1 |
| Canty, JM; Fallavollita, JA; Trojan, C | 1 |
| Abraham, SA; Alpert, NM; Fischman, AJ; Gewirtz, H; Picard, MH; Skopicki, HA; Tawakol, A | 1 |
| Fujii, K; Kuroda, T; Kuwabara, Y; Masuda, Y; Matsuno, K; Mikami, Y; Saito, T; Watanabe, S | 1 |
| Fujibayashi, Y; Itoh, H; Lee, JD; Nakano, A; Sadato, N; Sugimoto, K; Takahashi, N; Tsuchida, T; Waki, A; Welch, MJ; Yonekura, Y | 1 |
| Fujibayashi, Y; Fujita, M; Hirai, T; Hosokawa, R; Konishi, J; Magata, Y; Nohara, R; Sasayama, S; Tadamura, E | 1 |
| Gannon, MC; Haspel, HC; Lange, A; Liow, JS; Marx, D; McFalls, EO; Murad, B; Sikora, J; Ward, HB | 1 |
| Ishii, Y; Itoh, H; Lee, JD; Nakano, A; Sadato, N; Sugimoto, K; Takahashi, N; Tsuchida, T; Waki, A; Yonekura, Y | 1 |
| Schelbert, HR | 1 |
| Daher, E; DiBella, EV; Heller, EN; Liu, YH; Shi, CQ; Sinusas, AJ; Soufer, R; Wackers, FJ; Young, LH; Zoghbi, S | 1 |
| Segall, G | 1 |
| Baker, CS; Banner, NR; Bonser, RS; Camici, PG; Chareonthaitawee, P; Iozzo, P; Rimoldi, O; Schaefers, K; Stegger, L; Turkheimer, F; Yacoub, M | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; Valkema, R; Vourvouri, EC | 1 |
| Bax, JJ; Boersma, E; Camici, PG; Fath-Ordoubadi, F; Wijns, W | 1 |
| Bax, JJ; Blanksma, PK; Crijns, HJ; Vaalburg, W; van den Heuvel, AF; van Veldhuisen, DJ | 1 |
| Barkhausen, J; Brandt-Mainz, K; Freudenberg, L; Hunold, P; Knipp, S; Neumann, T; Vogt, FM | 1 |
| Ban, T; Hirata, K; Kambara, H; Kawai, C; Konishi, J; Nohara, R; Ohtani, H; Shindo, M; Tamaki, N; Yonekura, Y | 1 |
| Beller, GA; Gimple, LW; Ragosta, M; Watson, DD | 1 |
| Czernin, J; Porenta, G; Schelbert, H | 1 |
| Au-Yeung, KK; O, K; Siow, YL; Zhu, DY | 1 |
30 review(s) available for fluorodeoxyglucose f18 and Myocardial Ischemia
| Article | Year |
|---|---|
Assessment of myocardial viability by PET.
Topics: Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Magnetic Resonance Imaging; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Survival | 2019 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Likely Common Role of Hypoxia in Driving
Topics: Fluorodeoxyglucose F18; Glucose; Humans; Hypoxia; Inflammation; Myocardial Ischemia; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2021 |
Molecular Imaging of Myocardial Inflammation With Positron Emission Tomography Post-Ischemia: A Determinant of Subsequent Remodeling or Recovery.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Inflammation Mediators; Molecular Imaging; Myocardial Ischemia; Myocarditis; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recovery of Function; Ventricular Remodeling | 2018 |
[7. Nuclear cardiology in ischemic heart disease].
Topics: Coronary Angiography; Coronary Circulation; Electrocardiography; Energy Metabolism; Exercise Test; Fluorodeoxyglucose F18; Heart; Multimodal Imaging; Myocardial Ischemia; Myocardium; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk; Software; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2014 |
Cardiac Hot Spot Imaging With (18)FDG.
Topics: Animals; Diagnostic Imaging; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Sarcoidosis | 2014 |
Hexokinase-mitochondrial interaction in cardiac tissue: implications for cardiac glucose uptake, the 18FDG lumped constant and cardiac protection.
Topics: Animals; Cardiotonic Agents; Fluorodeoxyglucose F18; Glucose; Glucose-6-Phosphate; Hexokinase; Humans; Insulin; Mitochondria, Heart; Myocardial Ischemia; Myocardium; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Radiopharmaceuticals | 2009 |
Exercise (18)FDG imaging for the detection of CAD: What are the clinical hurdles?
Topics: Coronary Artery Disease; Exercise Test; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment | 2010 |
Assessment of myocardial ischaemia and viability: role of positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Revascularization; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2010 |
Fatty acid imaging of the heart.
Topics: Diabetic Cardiomyopathies; Fatty Acids; Fluorodeoxyglucose F18; Heart Diseases; Humans; Myocardial Ischemia; Myocardium; Obesity; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2011 |
The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction.
Topics: Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Myocardium; Quality Control; Radiopharmaceuticals; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2002 |
Myocardial metabolic and receptor imaging in idiopathic dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Cerebrovascular Circulation; Energy Metabolism; Fatty Acids; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Myocardial Ischemia; Myocardium; Parasympathetic Nervous System; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Adrenergic; Receptors, Adrenergic, beta; Receptors, Cell Surface; Receptors, Muscarinic; Sympathetic Nervous System | 2002 |
Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography?
Topics: Echocardiography, Stress; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Myocardial Reperfusion; Perfusion; Radiopharmaceuticals; Recovery of Function; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2003 |
Pathophysiology and diagnosis of hibernating myocardium in patients with post-ischemic heart failure: the contribution of PET.
Topics: Blood Flow Velocity; Coronary Circulation; Coronary Vessels; Fluorodeoxyglucose F18; Glucose; Heart; Heart Failure; Humans; Myocardial Ischemia; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
Myocardial viability: nuclear assessment.
Topics: Fluorodeoxyglucose F18; Heart Failure; Humans; Myocardial Ischemia; Myocardial Revascularization; Radiopharmaceuticals; Technetium; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2005 |
[Positron emission tomography with (18)F-fluoro-2-deoxyglucose in cardiological diagnosis].
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Severity of Illness Index | 2005 |
[PET?: comfortable whole body checkup].
Topics: Adult; Aged; Brain Diseases; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging | 2006 |
Visualization of transplanted cells within the myocardium.
Topics: Animals; Cell Count; Contrast Media; Echocardiography; Fluorodeoxyglucose F18; Humans; Image Enhancement; Luminescent Proteins; Magnetic Resonance Imaging; Microscopy; Myocardial Ischemia; Myocardium; Radiopharmaceuticals; Stem Cell Transplantation; Tomography, Emission-Computed | 2008 |
[Potential and limitation of myocardial perfusion scintigraphy for detection of viability].
Topics: Coronary Disease; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Thallium Radioisotopes; Tomography, Emission-Computed | 1995 |
Metabolic complexities in cardiac imaging.
Topics: Animals; Deoxyglucose; False Positive Reactions; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Tomography, Emission-Computed | 1995 |
Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
Topics: Blood Glucose; Carbon Radioisotopes; Coronary Disease; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Heart Failure; Heart Transplantation; Humans; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Oxygen Consumption; Postoperative Complications; Prognosis; Tomography, Emission-Computed; Ventricular Function, Left | 1994 |
Comparison of thallium scintigraphy and positron emission tomography.
Topics: Ammonia; Cardiomyopathies; Coronary Circulation; Coronary Disease; Cost-Benefit Analysis; Fluorodeoxyglucose F18; Glucose; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Nitrogen Radioisotopes; Prognosis; Radiopharmaceuticals; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed; Ventricular Function, Left | 1997 |
PET versus SPECT for determining myocardial tissue viability using fluorine-18-fluorodeoxyglucose.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Heart; Humans; Myocardial Ischemia; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
[Positron emission tomography of the heart. From research to clinical practice].
Topics: Coronary Circulation; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardial Ischemia; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
[Myocardial tissue vitality: clinical relevance, pathophysiology and identification].
Topics: Coronary Circulation; Fluorodeoxyglucose F18; Glucose; Humans; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Predictive Value of Tests; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
Fluorine-18-fluorodeoxyglucose cardiac imaging using a modified scintillation camera.
Topics: Equipment Design; Fluorodeoxyglucose F18; Gamma Cameras; Heart; Humans; Myocardial Ischemia; Phantoms, Imaging; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1998 |
18F-deoxyglucose and the assessment of myocardial viability.
Topics: Animals; Blood Glucose; Coronary Disease; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Myocardium; Radiopharmaceuticals; Regional Blood Flow; Tissue Survival; Tomography, Emission-Computed; Ventricular Function, Left | 2002 |
Assessment of myocardial viability by positron emission tomography.
Topics: Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Myocardial thallium-201 scintigraphy for assessment of viability in patients with severe left ventricular dysfunction.
Topics: Animals; Cell Survival; Coronary Vessels; Deoxyglucose; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Myocardium; Thallium Radioisotopes; Tomography, Emission-Computed; Ventricular Function, Left | 1992 |
[Positron emission tomography: principles and uses in cardiology].
Topics: Coronary Disease; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardium; Tomography, Emission-Computed | 1992 |
16 trial(s) available for fluorodeoxyglucose f18 and Myocardial Ischemia
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Low whole-body insulin sensitivity in patients with ischaemic heart disease is associated with impaired myocardial glucose uptake predictive of poor outcome after revascularisation.
Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Insulin Resistance; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2002 |
Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy.
Topics: Dobutamine; Echocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Stunning; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Single-Blind Method; Stress, Physiological; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease.
Topics: Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Diabetes Complications; Diabetes Mellitus; Exercise Test; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Sestamibi | 2003 |
Combined study with FDG PET and Tl SPECT in patients with idiopathic dilated cardiomyopathy.
Topics: Age Factors; Cardiomyopathy, Dilated; Diagnosis, Differential; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Myocardial Ischemia; Prognosis; Radiation-Protective Agents; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sex Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods.
Topics: Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Multicenter Studies as Topic; Myocardial Ischemia; Myocardial Revascularization; Randomized Controlled Trials as Topic; Research Design; Surgery, Computer-Assisted; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2003 |
Postinjection transmission scanning in myocardial 18F-FDG PET studies using both filtered backprojection and iterative reconstruction.
Topics: Algorithms; Blood Glucose; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Reproducibility of Results; Time Factors; Tomography, Emission-Computed | 2004 |
Ischemic and viable myocardium in patients with non-Q-wave or Q-wave myocardial infarction and left ventricular dysfunction: a clinical study using positron emission tomography, echocardiography, and electrocardiography.
Topics: Case-Control Studies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Prognosis; Radiopharmaceuticals; Rubidium Radioisotopes; Stroke Volume; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2004 |
[New approaches to the treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium].
Topics: Collateral Circulation; Combined Modality Therapy; Coronary Angiography; Echocardiography; Electrocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Organophosphorus Compounds; Organotechnetium Compounds; Quality of Life; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vascular Endothelial Growth Factor A | 2004 |
Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction.
Topics: Comorbidity; Coronary Artery Bypass; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Netherlands; Outcome Assessment, Health Care; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease.
Topics: Administration, Cutaneous; Ammonia; Angina Pectoris; Coronary Circulation; Deoxyglucose; Double-Blind Method; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Ischemia; Nitrogen Radioisotopes; Nitroglycerin; Tomography, Emission-Computed | 1995 |
[Noninvasive and simple method for the estimation of myocardial metabolic rate of glucose by PET and 18F-FDG].
Topics: Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Tomography, Emission-Computed | 1994 |
The limited role of myocardial fluorine-18 fluorodeoxyglucose imaging in candidates for cardiac transplantation: a planar imaging study.
Topics: Adult; Aged; Coronary Circulation; Female; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1998 |
Detection of myocardial viability using rest-redistribution thallium-201 imaging in a stress 99Tcm-tetrofosmin/rest thallium-201 dual-isotope protocol.
Topics: Aged; Exercise Test; Female; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Rest; Thallium; Thallium Radioisotopes; Tomography, Emission-Computed | 2001 |
Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction.
Topics: Adult; Aged; Chronic Disease; Coronary Circulation; Coronary Vessels; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Oxygen Radioisotopes; Postoperative Period; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left; Water | 2002 |
128 other study(ies) available for fluorodeoxyglucose f18 and Myocardial Ischemia
| Article | Year |
|---|---|
FDG hypermetabolism in myocardial ischemia without flow-limiting lesions: Possible role of coronary microvascular dysfunction.
Topics: Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Fluorodeoxyglucose F18; Humans; Microcirculation; Myocardial Ischemia | 2023 |
Incremental value of
Topics: Coronary Artery Disease; Dobutamine; Echocardiography, Stress; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Positron-Emission Tomography | 2022 |
Cardiac
Topics: Coronary Artery Disease; Diagnostic Imaging; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Topics: Autopsy; Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients.
Topics: Aged; Cicatrix; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Nitrogen Radioisotopes; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity | 2021 |
Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value.
Topics: Aged; Cardiomyopathies; Death, Sudden, Cardiac; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Low-dose PET image noise reduction using deep learning: application to cardiac viability FDG imaging in patients with ischemic heart disease.
Topics: Adult; Deep Learning; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Ischemia; Positron-Emission Tomography; Radiation Dosage; Signal-To-Noise Ratio; Stroke Volume; Tissue Survival | 2021 |
The importance of 18F-FDG cardiac PET/CT for the assessment of myocardial viability in ischaemic heart disease.
Topics: Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac
Topics: Coronary Circulation; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Humans; Insulin Resistance; Male; Myocardial Ischemia; Positron-Emission Tomography; Retrospective Studies | 2021 |
Patterns of [18F]FDG myocardial uptake in oncology patients as a predictor of myocardial ischaemia on stress myocardial perfusion imaging.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Myocardial Perfusion Imaging; Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2021 |
Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion.
Topics: Aged; Cardiomyopathies; Contrast Media; Coronary Angiography; Coronary Occlusion; Female; Fluorodeoxyglucose F18; Gadolinium; Heart; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2019 |
Clinical significance of quantitative assessment of glucose utilization in patients with ischemic cardiomyopathy.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2020 |
Non-diagnostic
Topics: Aged; Cardiomyopathies; Diabetes Mellitus, Type 2; Fatty Acids; Fluorodeoxyglucose F18; Heart; Humans; Insulin; Male; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Patient Compliance; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon | 2019 |
A quick glance at selected topics in this issue.
Topics: Cardiology; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Myocardial Perfusion Imaging; Nuclear Medicine; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Risk Assessment; Tomography, Emission-Computed, Single-Photon | 2019 |
Role of quantitative myocardial blood flow and
Topics: Aged; Ammonia; Coronary Circulation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve | 2021 |
No differences in rest myocardial blood flow in stunned and hibernating myocardium: insights into the pathophysiology of ischemic cardiomyopathy.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Motion; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Ventricular Dysfunction, Left | 2019 |
[68Ga]-albumin-PET in the monitoring of left ventricular function in murine models of ischemic and dilated cardiomyopathy: comparison with cardiac MRI.
Topics: Albumins; Animals; Cardiomyopathy, Dilated; Disease Models, Animal; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mice; Multimodal Imaging; Myocardial Ischemia; Positron-Emission Tomography; Tissue Distribution; Ventricular Function, Left | 2013 |
Myocardial viability: whom, what, why, which, and how?
Topics: Algorithms; Cardiac Imaging Techniques; Diagnostic Imaging; Echocardiography, Stress; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Myocardial Revascularization; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2013 |
Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Revascularization; Myocardial Stunning; Myocardium; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Radiopharmaceuticals; Recovery of Function; Risk Assessment; Risk Factors; Rubidium Radioisotopes; Stroke Volume; Time Factors; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2013 |
The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction.
Topics: Cardiomyopathies; Coronary Artery Bypass; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Stunning; Myocardium; Patient Selection; Percutaneous Coronary Intervention; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2013 |
Genetic deletion in uncoupling protein 3 augments 18F-fluorodeoxyglucose cardiac uptake in the ischemic heart.
Topics: Animals; Disease Models, Animal; Fluorodeoxyglucose F18; Genotype; Glycolysis; Heart Ventricles; Ion Channels; Male; Mice, 129 Strain; Mice, Knockout; Mitochondrial Proteins; Multimodal Imaging; Myocardial Ischemia; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uncoupling Protein 3 | 2014 |
Comparison of Tc-99m tetrofosmin myocardial perfusion scintigraphy and exercise F18-FDG imaging in detection of myocardial ischemia in patients with coronary artery disease.
Topics: Adult; Aged; Constriction, Pathologic; Coronary Angiography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Young Adult | 2015 |
Direct myocardial ischemia imaging with exercise ¹⁸FDG.
Topics: Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Myocardial Ischemia; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Radionuclide Imaging | 2015 |
Mixture of ischemia and hibernation in a patient with severe diagonal disease: Value of perfusion and metabolic PET imaging.
Topics: Coronary Angiography; Drug-Eluting Stents; Electrocardiography; Fluorodeoxyglucose F18; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Ischemia; Perfusion; Positron-Emission Tomography; Purines; Pyrazoles; Rubidium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2015 |
'Hot spot' cardiac ischemia imaging with fluorodeoxyglucose positron emission tomography.
Topics: Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Identification of Angiogenesis Rich-Viable Myocardium using RGD Dimer based SPECT after Myocardial Infarction.
Topics: Animals; Fluorodeoxyglucose F18; Integrin alphaVbeta3; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Neovascularization, Pathologic; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed, Single-Photon | 2016 |
In Vivo Dynamic Metabolic Changes After Transplantation of Induced Pluripotent Stem Cells for Ischemic Injury.
Topics: Animals; Electrocardiography; Fluorodeoxyglucose F18; Induced Pluripotent Stem Cells; Male; Myocardial Ischemia; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley | 2016 |
[Application value of combination of
Topics: Adult; Aged; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Positron-Emission Tomography; Ventricular Function, Left | 2016 |
Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
Topics: Aged; Cardiomyopathies; Coronary Circulation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Rubidium Radioisotopes; Ventricular Dysfunction, Left | 2008 |
Myocardial 18F-FDG uptake after exercise-induced myocardial ischemia in patients with coronary artery disease.
Topics: Coronary Artery Disease; Exercise Test; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Clearance Rate; Middle Aged; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
18F-FDG uptake as a surrogate marker for antecedent ischemia.
Topics: Coronary Artery Disease; Exercise Test; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Relation of brain natriuretic peptide level to extent of left ventricular scarring in patients with chronic heart failure secondary to ischemic cardiomyopathy.
Topics: Aged; Chi-Square Distribution; Cicatrix; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2009 |
Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease.
Topics: Aged; Ammonia; Coronary Circulation; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Nitrogen Radioisotopes; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Stroke Volume; Ventricular Function, Left | 2009 |
Myocardial viability in chronic ischemic heart disease: comparison of delayed-enhancement magnetic resonance imaging with 99mTc-sestamibi and 18F-fluorodeoxyglucose single-photon emission computed tomography.
Topics: Chronic Disease; Cicatrix; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Middle Aged; Myocardial Ischemia; Technetium Tc 99m Sestamibi; Time Factors; Tissue Survival; Tomography, Emission-Computed, Single-Photon | 2009 |
Direct imaging of myocardial ischaemia with [18F]fluorodeoxyglucose on exercise PET in hypertrophic cardiomyopathy.
Topics: Cardiomyopathy, Hypertrophic; Exercise Test; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
Diagnosis of silent myocardial ischemia during the staging of HIV-associated lymphoma with FDG PET/CT.
Topics: Fluorodeoxyglucose F18; HIV Infections; Humans; Lymphoma; Male; Middle Aged; Myocardial Ischemia; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Effect of lateral wall scar on reverse remodeling with cardiac resynchronization therapy.
Topics: Aged; Bundle-Branch Block; Cardiac Resynchronization Therapy; Cardiomyopathies; Confidence Intervals; Female; Fibrosis; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Odds Ratio; Positron-Emission Tomography; Prospective Studies; ROC Curve; Rubidium; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon; Ventricular Remodeling | 2009 |
An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy.
Topics: Aged; Cardiomyopathies; Diabetes Complications; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Catheter ablation of ventricular tachycardias in patients with ischemic cardiomyopathy: validation of voltage mapping criteria for substrate modification by myocardial viability assessment using FDG PET.
Topics: Aged; Body Surface Potential Mapping; Catheter Ablation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals; Tachycardia, Ventricular; Treatment Outcome | 2010 |
Impact of CT attenuation correction on the viability pattern assessed by 99mTc-tetrofosmin SPECT/ 18F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Coronary Circulation; Coronary Stenosis; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Switzerland; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Metabolic imaging for identifying antecedent myocardial ischemia and acute coronary syndrome in the emergency department.
Topics: Acute Coronary Syndrome; Chest Pain; Electrocardiography; Emergency Service, Hospital; Fatty Acids; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon | 2011 |
[[Practice guidelines for FDG PET, PET/CT].
Topics: Epilepsy; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Safety Management; Tomography, X-Ray Computed | 2010 |
Treadmill exercise inducing mild to moderate ischemia has no significant effect on skeletal muscle or cardiac 18F-FDG uptake and image quality on subsequent whole-body PET scan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Exercise Test; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscle, Skeletal; Myocardial Ischemia; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Whole Body Imaging | 2012 |
Arteriosclerosis of whole aorta in takayasu arteritis.
Topics: Adult; Aorta; Arteriosclerosis; Colitis, Ischemic; Female; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis | 2012 |
Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
Topics: Aged; Coronary Artery Disease; Coronary Circulation; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Insulin Resistance; Male; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2012 |
Blood flow, flow reserve, and glucose utilization in viable and nonviable myocardium in patients with ischemic cardiomyopathy.
Topics: Adult; Aged; Blood Glucose; Cardiomyopathies; Case-Control Studies; Female; Fluorodeoxyglucose F18; Fractional Flow Reserve, Myocardial; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Nitrogen Radioisotopes; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow | 2013 |
Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction.
Topics: Coronary Circulation; Coronary Vessels; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Cerebrovascular Circulation; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 2; Heart Ventricles; In Vitro Techniques; Male; Monosaccharide Transport Proteins; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Quality Control; Radiopharmaceuticals; Rats; Rats, Wistar; Reference Values; Reproducibility of Results; Sensitivity and Specificity | 2002 |
Comparison of positron emission tomography with the resting electrocardiogram for assessing viable myocardium in chronic ischemic cardiomyopathy involving the anterior left ventricular wall.
Topics: Aged; Chronic Disease; Coronary Angiography; Electrocardiography; Energy Metabolism; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Necrosis; Predictive Value of Tests; Prognosis; Tissue Survival; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2002 |
Repetitive supply-demand ischemia with dobutamine increases glucose uptake in postischemic and remote myocardium.
Topics: Animals; Benzamides; Dobutamine; Fasting; Female; Fluorodeoxyglucose F18; Glucose; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Swine; Tomography, Emission-Computed | 2003 |
Dobutamine responsiveness, PET mismatch, and lack of necrosis in low-flow ischemia: is this hibernation in the isolated rat heart?
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Creatine Kinase; Dobutamine; Fluorodeoxyglucose F18; Heart; In Vitro Techniques; Lactic Acid; Male; Microscopy, Electron; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Necrosis; Radiopharmaceuticals; Rats; Rats, Wistar; Stroke Volume; Tomography, Emission-Computed; Ventricular Function, Left | 2003 |
Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Research Design; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
Evaluation of myocardial viability in chronic ischemic cardiomyopathy.
Topics: Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2003 |
Relation between QT dispersion and myocardial viability in ischemic cardiomyopathy.
Topics: Aged; Cardiomyopathies; Coronary Artery Disease; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Does chronic ST segment elevation following Q wave myocardial infarction exclude tissue viability?
Topics: Aged; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Risk Factors; Tissue Survival; Tomography, Emission-Computed | 2003 |
Relationship between exercise-induced myocardial ischemia and reduced left ventricular distensibility in patients with nonobstructive hypertrophic cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Diastole; Exercise; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2003 |
Myocardial ischemia, fluorodeoxyglucose, and severity of coronary artery stenosis: the complexities of metabolic remodeling in hibernating myocardium.
Topics: Coronary Stenosis; Energy Metabolism; Exercise Test; Fasting; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Sampling Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2004 |
Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium.
Topics: Animals; Cells, Cultured; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Genes, Reporter; Genetic Therapy; Genetic Vectors; Guanine; Heart; Heart Ventricles; Kinetics; Myocardial Contraction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Neovascularization, Physiologic; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Transduction, Genetic; Ultrasonography; Vascular Endothelial Growth Factor A | 2004 |
Comparison of real-time myocardial contrast echocardiography for the assessment of myocardial viability with fluorodeoxyglucose-18 positron emission tomography and dobutamine stress echocardiography.
Topics: Adult; Aged; Cell Survival; Echocardiography; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed | 2004 |
Assessment of myocardial viability by nuclear imaging techniques.
Topics: Animals; Cardiomyopathies; Diabetes Complications; Disease Models, Animal; Echocardiography, Stress; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardial Stunning; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Stroke Volume; Swine; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2005 |
Post-systolic shortening during dobutamine stress echocardiography predicts cardiac survival in patients with severe left ventricular dysfunction.
Topics: Cardiomyopathies; Coronary Artery Bypass; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Netherlands; Prognosis; Prospective Studies; Radiopharmaceuticals; Stroke Volume; Survival Analysis; Systole; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ultrasonography, Doppler, Pulsed; Ventricular Dysfunction, Left | 2005 |
Glucose uptake in normal and ischemically jeopardized myocardium measured by 18 F-fluorodeoxyglucose and positron emmision tomography.
Topics: Animals; Coronary Circulation; Dogs; Female; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Insulin; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction.
Topics: Aged; Chronic Disease; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Myocardial Ischemia; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2005 |
Myocardial ischaemia and metabolic memory.
Topics: Fatty Acids, Nonesterified; Fluorodeoxyglucose F18; Glucose; Humans; Metabolic Clearance Rate; Myocardial Ischemia; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Positron-Emission Tomography; Survival Analysis; Systole; Tissue Survival; Ventricular Dysfunction, Left | 2006 |
Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.
Topics: Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2006 |
Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up.
Topics: Adult; Aged; Aged, 80 and over; Cells, Cultured; Chronic Disease; Coronary Artery Bypass; Echocardiography, Stress; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myoblasts, Skeletal; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals; Stroke Volume; Transplantation, Autologous; Ventricular Function, Left | 2006 |
Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.
Topics: Aged; Angina Pectoris; Bone Marrow Transplantation; Chronic Disease; Drug Resistance; Fluorodeoxyglucose F18; Humans; Injections; Leukocytes, Mononuclear; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Transplantation, Autologous; Ventricular Function, Left | 2006 |
[Clinical impact of positron emission tomography by coincidence system with 18F-FDG on therapeutic decision-making of patients with ischemic cardiomyopathy after myocardial infarction].
Topics: Decision Making, Computer-Assisted; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 2006 |
Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients.
Topics: Aged; Cardiac Pacing, Artificial; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2006 |
FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy.
Topics: Aged; Cardiac Pacing, Artificial; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Myocardial Ischemia; Patient Selection; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2007 |
Selection of heart failure patients for cardiac resynchronisation therapy: a role for PET?
Topics: Cardiac Output, Low; Cardiac Pacing, Artificial; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Patient Selection; Positron-Emission Tomography; Prognosis; Risk Assessment; Risk Factors; Treatment Outcome | 2007 |
[18F]Fluorodeoxyglucose as a memory marker of transient myocardial ischaemia.
Topics: Aged; Angiography; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Myocardial Ischemia; Myocardium; Perfusion; Positron-Emission Tomography; Pressure; Reproducibility of Results; Time Factors; Tomography, Emission-Computed, Single-Photon | 2007 |
Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging and comparison with single-photon emission computed tomography.
Topics: Female; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Myocardium; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon | 2006 |
[Myocardial viability assessment and perioperative cardiovascular evaluation using single photon emission tomography and positron emission tomography].
Topics: Coronary Circulation; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Survival; Tomography, Emission-Computed, Single-Photon | 2007 |
Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG.
Topics: Deoxyglucose; Feasibility Studies; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Ischemia; Myocardium; Phantoms, Imaging; Predictive Value of Tests; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1995 |
Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Topics: Coronary Angiography; Coronary Disease; Deoxyglucose; Dipyridamole; Exercise Test; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Predictive Value of Tests; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1995 |
Comparison of fluorine-18-fluorodeoxyglucose and tritiated fluoromisonidazole uptake during low-flow ischemia.
Topics: Animals; Coronary Circulation; Deoxyglucose; Dogs; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Misonidazole; Myocardial Ischemia; Radionuclide Imaging; Sensitivity and Specificity; Tritium | 1995 |
Assessment of myocardial viability: where are we?
Topics: Deoxyglucose; Dobutamine; Echocardiography; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Quantitative myocardial mapping of perfusion and metabolism using parametric polar map displays in cardiac PET.
Topics: Adult; Aged; Coronary Angiography; Coronary Circulation; Deoxyglucose; Dipyridamole; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Predictive Value of Tests; Tomography, Emission-Computed | 1995 |
Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography.
Topics: Adult; Aged; Animals; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Tomography, Emission-Computed | 1995 |
Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability.
Topics: Cell Survival; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardium; Radionuclide Imaging; Rubidium Radioisotopes | 1995 |
Ischemic hibernating myocardium demonstrated by positron emission tomography in anomalous origin of the left coronary artery from the pulmonary artery.
Topics: Adult; Ammonia; Coronary Circulation; Coronary Vessel Anomalies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Nitrogen Radioisotopes; Pulmonary Artery; Tomography, Emission-Computed; Ventricular Function, Left | 1994 |
Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
Topics: Aged; Angioplasty, Balloon, Coronary; Blood Glucose; Circadian Rhythm; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Deoxyglucose; Energy Metabolism; Exercise Test; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Monitoring, Physiologic; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 1994 |
[Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
Topics: Aged; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism.
Topics: Adult; Aged; Deoxyglucose; Exercise Test; Fatty Acids; Female; Fluorodeoxyglucose F18; Glucose; Humans; Iodobenzenes; Male; Middle Aged; Myocardial Ischemia; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique.
Topics: Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels; Deoxyglucose; Dipyridamole; Fluorodeoxyglucose F18; Heart Rate; Humans; Middle Aged; Myocardial Ischemia; Oxygen Radioisotopes; Tomography, Emission-Computed; Ultrasonography; Water | 1993 |
[Myocardial revascularization in patients with compromised left ventricular function].
Topics: Chi-Square Distribution; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Humans; Italy; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Risk Factors; Survival Analysis; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 1993 |
Fluorodeoxyglucose, myocardial perfusion and myocardial cell death.
Topics: Cell Death; Coronary Circulation; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Radionuclide Imaging | 1993 |
Myocardial glucose metabolism and ATP levels are decreased two days after global ischemia.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Blood Glucose; Cardiopulmonary Bypass; Deoxyglucose; Dogs; Fatty Acids, Nonesterified; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Lactates; Myocardial Ischemia; Myocardium; Oxygen Consumption; Phosphocreatine; Time Factors; Tomography, Emission-Computed | 1996 |
Myocardial metabolic changes in hypertrophic cardiomyopathy.
Topics: Acetates; Adult; Carbon Radioisotopes; Cardiomyopathy, Hypertrophic; Case-Control Studies; Deoxyglucose; Echocardiography; Energy Metabolism; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Myocardial Ischemia; Myocardium; Tomography, Emission-Computed | 1996 |
Clinical importance of viability assessment in chronic ischemic heart failure.
Topics: Chronic Disease; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 1996 |
The use of low-dose intravenous insulin in clinical myocardial F-18 FDG PET scanning.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Injections, Intravenous; Insulin; Myocardial Ischemia; Tomography, Emission-Computed | 1996 |
Factors influencing regional myocardial contractile response to inotropic stimulation. Analysis in humans with stable ischemic heart disease.
Topics: Adenosine; Adrenergic beta-Agonists; Aged; Ammonia; Carbon Isotopes; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Deoxyglucose; Dobutamine; Echocardiography; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
Topics: Adult; Aged; Ammonia; Carbon Isotopes; Chronic Disease; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Deoxyglucose; Dobutamine; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1996 |
Paradoxical uptake of F-18 fluorodeoxyglucose by successfully reperfused myocardium during the sub-acute phase in patients with acute myocardial infarction.
Topics: Aged; Animals; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Simple method to quantify myocardial glucose metabolism from MB ratio in myocardial FDG PET.
Topics: Adult; Deoxyglucose; Fasting; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Insulin; Myocardial Ischemia; Myocardium; Regression Analysis; Reproducibility of Results; Tomography, Emission-Computed | 1996 |
Segmented attenuation correction using artificial neural networks in positron tomography.
Topics: Ammonia; Coronary Circulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart; Humans; Mathematics; Models, Structural; Myocardial Ischemia; Neural Networks, Computer; Nitrogen Radioisotopes; Phantoms, Imaging; Reproducibility of Results; Tomography, Emission-Computed | 1996 |
A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography.
Topics: Case-Control Studies; Exercise Test; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Glucose Tolerance Test; Heart; Humans; Insulin; Male; Middle Aged; Myocardial Ischemia; Potassium; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1997 |
Effects of wortmannin on insulin- and ischemia-induced stimulation of GLUT4 translocation and FDG uptake in perfused rat hearts.
Topics: Androstadienes; Animals; Biological Transport; Cell Membrane; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Transporter Type 4; Immunoblotting; Insulin Antagonists; Intracellular Membranes; Male; Monosaccharide Transport Proteins; Muscle Proteins; Myocardial Ischemia; Perfusion; Phosphoinositide-3 Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Signal Transduction; Wortmannin | 1997 |
Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake.
Topics: Aged; Cardiac Catheterization; Fatty Acids, Nonesterified; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart; Humans; Hyperinsulinism; Male; Middle Aged; Myocardial Ischemia; Myocardium; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1998 |
Profound underestimation of glucose uptake by [18F]2-deoxy-2-fluoroglucose in reperfused rat heart muscle.
Topics: Animals; Cardioplegic Solutions; Citrate (si)-Synthase; Fluorodeoxyglucose F18; Glucose; Heart; Hexokinase; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Oleic Acid; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed; Tromethamine | 1998 |
Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction.
Topics: Adult; Aged; Animals; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Predictive Value of Tests; Radionuclide Ventriculography; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Prediction of myocardial viability: Tl-201 versus sestamibi versus teboroxime compared with FDG uptake.
Topics: Coronary Circulation; Female; Fluorodeoxyglucose F18; Forecasting; Heart; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Organotechnetium Compounds; Oximes; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tissue Survival | 1998 |
Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Aged; Ammonia; Coronary Angiography; Coronary Circulation; Electrocardiography; Fasting; Female; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Nitrogen Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Ischemia and left ventricular dysfunction: a reciprocal relation?
Topics: Adult; Blood Flow Velocity; Coronary Disease; Dipyridamole; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Platelet Aggregation Inhibitors; Radiopharmaceuticals; Ventricular Dysfunction, Left | 1998 |
Glucose tolerance and myocardial F-18 fluorodeoxyglucose uptake in normal regions in coronary heart disease patients.
Topics: Aged; Coronary Disease; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Glucose; Glucose Tolerance Test; Heart; Humans; Image Processing, Computer-Assisted; Insulin Resistance; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Variability of the lumped constant for [18F]2-deoxy-2-fluoroglucose and the experimental isolated rat heart model: clinical perspectives for the measurement of myocardial tissue viability in humans.
Topics: Animals; Cell Survival; Fluorodeoxyglucose F18; Humans; In Vitro Techniques; Myocardial Ischemia; Myocardium; Rats | 1999 |
Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Echocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Ischemia; Prognosis; Prospective Studies; Quality of Life; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Contribution of alpha-adrenergic and beta-adrenergic stimulation to ischemia-induced glucose transporter (GLUT) 4 and GLUT1 translocation in the isolated perfused rat heart.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Biological Transport; Cell Fractionation; Cell Membrane; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 4; Isoproterenol; Male; Monosaccharide Transport Proteins; Muscle Fibers, Skeletal; Muscle Proteins; Myocardial Ischemia; Myocardium; Organ Culture Techniques; Perfusion; Phentolamine; Phenylephrine; Propranolol; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Signal Transduction | 1999 |
Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
Topics: Aged; Aged, 80 and over; Cardiac Catheterization; Echocardiography; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Kinetics; Male; Middle Aged; Models, Biological; Myocardial Ischemia; Myocardium; Radioactive Tracers; Tomography, Emission-Computed | 1999 |
Differential uptake of FDG and DG during post-ischaemic reperfusion in the isolated, perfused rat heart.
Topics: Animals; Antimetabolites; Deoxyglucose; Fluorodeoxyglucose F18; In Vitro Techniques; Magnetic Resonance Spectroscopy; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Radiopharmaceuticals; Rats; Tomography, Emission-Computed | 1999 |
Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Heart; Humans; Myocardial Ischemia; Myocardial Stunning; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1999 |
Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Circulation; Dipyridamole; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Hyperemia; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Reference Values; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2000 |
[Progress in nuclear diagnosis].
Topics: Fatty Acids; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Iodobenzenes; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2000 |
Transmural distribution of FDG uptake in stunned myocardium.
Topics: Animals; Blood Pressure; Coronary Circulation; Fluorodeoxyglucose F18; Heart; Heart Rate; Hemodynamics; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Reference Values; Swine; Tissue Distribution | 2000 |
Evidence of reduced resting blood flow in viable myocardial regions with chronic asynergy.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Coronary Circulation; Dobutamine; Female; Fluorodeoxyglucose F18; Hemodynamics; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Radiopharmaceuticals; Tomography, Emission-Computed; Ultrasonography | 2000 |
Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia.
Topics: Aged; Angina, Unstable; Biological Transport; Coordination Complexes; Copper Radioisotopes; Coronary Disease; Female; Fluorodeoxyglucose F18; Free Radical Scavengers; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Organometallic Compounds; Radiopharmaceuticals; Thiosemicarbazones; Tomography, Emission-Computed | 2001 |
Myocardial metabolism of 123I-BMIPP during low-flow ischaemia in an experimental model: comparison with myocardial blood flow and 18F-FDG.
Topics: Animals; Coronary Circulation; Fatty Acids; Fluorodeoxyglucose F18; Iodine Radioisotopes; Iodobenzenes; Lactic Acid; Male; Myocardial Ischemia; Myocardium; Tomography, Emission-Computed, Single-Photon | 2001 |
Glucose uptake and glycogen levels are increased in pig heart after repetitive ischemia.
Topics: Adenosine Triphosphate; Ammonia; Animals; Biological Transport; Coronary Circulation; Echocardiography; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 4; Glycogen; Heart; Hemodynamics; Hexokinase; Monosaccharide Transport Proteins; Muscle Proteins; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Nitrogen Isotopes; Phosphocreatine; Swine; Tomography, Emission-Computed | 2002 |
Myocardial FDG-PET examination during fasting and glucose loading states by means of a one-day protocol.
Topics: Aged; Algorithms; Blood Glucose; Coronary Artery Disease; Fasting; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Enhancement; Imaging, Three-Dimensional; Insulin; Male; Middle Aged; Myocardial Ischemia; Myocardium; Phantoms, Imaging; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |
Correlation of myocardial p-(123)I-iodophenylpentadecanoic acid retention with (18)F-FDG accumulation during experimental low-flow ischemia.
Topics: Animals; Coronary Circulation; Dogs; Fluorodeoxyglucose F18; Heart; Iodine Radioisotopes; Iodobenzenes; Myocardial Ischemia; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2002 |
Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose: a new absolute threshold technique.
Topics: Animals; Case-Control Studies; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart Ventricles; Hemodynamics; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Radiopharmaceuticals; Swine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |
Assessment of viable tissue in Q-wave regions by metabolic imaging using single-photon emission computed tomography in ischemic cardiomyopathy.
Topics: Aged; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Image Enhancement; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients.
Topics: Aged; Case-Control Studies; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyridamole; Echocardiography, Stress; Energy Metabolism; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Perfusion; Tomography, Emission-Computed; Vasodilator Agents | 2002 |
[Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
Topics: Aged; Coronary Circulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Reproducibility of Results; Tissue Survival; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2002 |
Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
Topics: Adult; Aged; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1992 |
Inhibition of stress-activated protein kinase in the ischemic/reperfused heart: role of magnesium tanshinoate B in preventing apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Cell Nucleus; Heart; In Vitro Techniques; Magnesium; Male; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenanthrolines; Protective Agents; Rats; Rats, Sprague-Dawley; Statistics as Topic; Subcellular Fractions | 2001 |